Copyright
©The Author(s) 2015.
World J Gastroenterol. Jul 21, 2015; 21(27): 8398-8407
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8398
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8398
Table 1 Risk level access of gastrointestinal stromal tumor
| Risk level | Tumor size (cm) | Mitotic count (50/HPF) | Primary tumor location |
| Very low | ≤ 2.0 | ≤ 5 | Any |
| Low | 2.1-5.0 | ≤ 5 | Any |
| Medium | 2.1-5.0 | > 5 | Stomach |
| < 5.0 | 6-10 | Any | |
| 5.1-10.0 | ≤ 5 | Stomach | |
| High | Any | Any | Tumor rupture |
| > 10.0 | Any | Any | |
| Any | > 10 | Any | |
| > 5.0 | > 5 | Any | |
| 2.1-5.0 | > 5 | Non stomach | |
| 5.1-10.0 | ≤ 5 | Non stomach |
- Citation: Wang CJ, Zhang ZZ, Xu J, Wang M, Zhao WY, Tu L, Zhuang C, Liu Q, Shen YY, Cao H, Zhang ZG. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis. World J Gastroenterol 2015; 21(27): 8398-8407
- URL: https://www.wjgnet.com/1007-9327/full/v21/i27/8398.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i27.8398